ARTICLE | Clinical News
Pharmacyclics completes Phase II Xcytrin enrollment
August 2, 2001 7:00 AM UTC
PCYC completed enrollment of 24 patients with newly diagnosed glioblastoma multiforme in a single-arm Phase II trial of its Xcytrin motexafin gadolinium radiosensitizer. The trial will assess safety a...